APM
BLUE

Avidity Partners Management’s bluebird bio BLUE Stock Holding History

Avidity Partners Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-81,555
Closed -$680K – 71
2024
Q4 		$680K Sell
81,555
-2
-0% -$17 0.07% 63
2024
Q3 		$847K Buy
+81,557
New +$1.36M 0.04% 80

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $8.31B AUM 37.53% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Avidity Partners Management's BLUE Position: Q1 2025 in Review

Avidity Partners Management sold out of bluebird bio (BLUE) in Q1 2025, closing a stake of 81,555 shares — an estimated $680K sold.

Avidity Partners Management first reported a position in BLUE in Q3 2024 and held it in 2 quarters. The position peaked at $847K in Q3 2024. 85 funds tracked by Wall St. Rank hold BLUE as of Q1 2025.

  • Avidity Partners Management reported no remaining bluebird bio position as of Q1 2025 after selling out during the quarter.
  • Avidity Partners Management sold 81,555 bluebird bio shares in Q1 2025, an estimated $680K.
  • Avidity Partners Management first reported a position in bluebird bio in Q3 2024 and held it in 2 quarters.
  • Avidity Partners Management's bluebird bio position peaked at $847K in Q3 2024.
  • 85 funds tracked by Wall St. Rank held bluebird bio as of Q1 2025.

Based on Avidity Partners Management's 13F filing for Q1 2025, filed 15 May 2025.